Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
Quick facts
Marketed products
- medical nutrition therapy + metformin · Endocrinology / Diabetes
Medical nutrition therapy combined with metformin reduces blood glucose through dietary management and insulin sensitization, respectively.
Phase 3 pipeline
- Orally Colostrum · Immunology / Gastroenterology
Oral colostrum provides passive immunological and nutritional support through bioactive compounds including immunoglobulins, lactoferrin, and growth factors.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes portfolio CI brief
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes pipeline updates RSS
Frequently asked questions about Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
What are Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes's marketed drugs?
Top marketed products include medical nutrition therapy + metformin.
What is Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes's pipeline?
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Orally Colostrum.
Related
- medical nutrition therapy + metformin · Endocrinology / Diabetes
- Sector hub: All tracked pharma companies